Literature DB >> 20124124

Ca2+ cycling and new therapeutic approaches for heart failure.

Anne-Marie Lompré1, Roger J Hajjar, Sian E Harding, Evangelia G Kranias, Martin J Lohse, Andrew R Marks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20124124      PMCID： PMC2834781          DOI： 10.1161/CIRCULATIONAHA.109.890954

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  118 in total

Review 1.  Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy.

Authors:  Kobra Haghighi; Kimberly N Gregory; Evangelia G Kranias
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

2.  Expression of the sarco/endoplasmic reticulum calcium ATPase type 2 and 3 isoforms in normal skin and Darier's disease.

Authors:  S Tavadia; K S Authi; M B Hodgins; C S Munro
Journal:  Br J Dermatol       Date:  2004-08       Impact factor: 9.302

3.  Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven R Reiken; Shi-Xian Deng; John A Vest; Daniel Cervantes; James Coromilas; Donald W Landry; Andrew R Marks
Journal:  Science       Date:  2004-04-09       Impact factor: 47.728

4.  Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy.

Authors:  Ismayil Ahmet; Melissa Krawczyk; Phillip Heller; Chanil Moon; Edward G Lakatta; Mark I Talan
Journal:  Circulation       Date:  2004-08-16       Impact factor: 29.690

5.  Regulation of myocardial function by histidine-rich, calcium-binding protein.

Authors:  Guo-Chang Fan; Kimberly N Gregory; Wen Zhao; Woo Jin Park; Evangelia G Kranias
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06-10       Impact factor: 4.733

6.  Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.

Authors:  Stephan E Lehnart; Xander H T Wehrens; Päivi J Laitinen; Steven R Reiken; Shi-Xiang Deng; Zhenzhuang Cheng; Donald W Landry; Kimmo Kontula; Heikki Swan; Andrew R Marks
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

Review 7.  Cardiac ryanodine receptor function and regulation in heart disease.

Authors:  Stephan E Lehnart; Xander H T Wehrens; Alexander Kushnir; Andrew R Marks
Journal:  Ann N Y Acad Sci       Date:  2004-05       Impact factor: 5.691

8.  Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.

Authors:  Xander H T Wehrens; Stephan E Lehnart; Steven R Reiken; Andrew R Marks
Journal:  Circ Res       Date:  2004-03-11       Impact factor: 17.367

9.  Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling.

Authors:  Federica del Monte; Djamel Lebeche; J Luis Guerrero; Tsuyoshi Tsuji; Angelia A Doye; Judith K Gwathmey; Roger J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

10.  Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias.

Authors:  Ying Chen; Brigitte Escoubet; Fabrice Prunier; Julien Amour; Warner S Simonides; Benoît Vivien; Christophe Lenoir; Michèle Heimburger; Christine Choqueux; Barnabas Gellen; Bruno Riou; Jean-Baptiste Michel; Wolfgang M Franz; Jean-Jacques Mercadier
Journal:  Circulation       Date:  2004-03-22       Impact factor: 29.690
View more
  51 in total

Review 1.  Calcium cycling proteins and their association with heart failure.

Authors:  L Hadri; R J Hajjar
Journal:  Clin Pharmacol Ther       Date:  2011-08-10       Impact factor: 6.875

2.  Mice lacking functional TRPV1 are protected from pressure overload cardiac hypertrophy.

Authors:  Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2011-07-01       Impact factor: 2.581

Review 3.  Novel therapeutic targets for the treatment of heart failure.

Authors:  Juan Tamargo; José López-Sendón
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

4.  Dysfunctional conformational dynamics of protein kinase A induced by a lethal mutant of phospholamban hinder phosphorylation.

Authors:  Jonggul Kim; Larry R Masterson; Alessandro Cembran; Raffaello Verardi; Lei Shi; Jiali Gao; Susan S Taylor; Gianluigi Veglia
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-09       Impact factor: 11.205

5.  [New therapy concepts for heart failure with preserved ejection fraction].

Authors:  C Tschöpe; B Pieske
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 6.  Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.

Authors:  Carsten Tschöpe; Sophie Van Linthout; Behrouz Kherad
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

Review 7.  Gene therapy to treat cardiac arrhythmias.

Authors:  Rossana Bongianino; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

8.  In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure.

Authors:  Anuradha Guggilam; Kirk R Hutchinson; T Aaron West; Amy P Kelly; Maarten L Galantowicz; Amy J Davidoff; Sakthivel Sadayappan; Pamela A Lucchesi
Journal:  J Mol Cell Cardiol       Date:  2012-12-07       Impact factor: 5.000

9.  Activation of CaMKIIδA promotes Ca2+ leak from the sarcoplasmic reticulum in cardiomyocytes of chronic heart failure rats.

Authors:  Le Gui; Xin Guo; Zhe Zhang; Hui Xu; Ya-Wei Ji; Ren-Jun Wang; Jiang-Hua Zhu; Qing-Hui Chen
Journal:  Acta Pharmacol Sin       Date:  2018-06-14       Impact factor: 6.150

10.  Short-term mechanical unloading with left ventricular assist devices after acute myocardial infarction conserves calcium cycling and improves heart function.

Authors:  Xufeng Wei; Tieluo Li; Brian Hagen; Pei Zhang; Pablo G Sanchez; Katrina Williams; Shuying Li; Giacomo Bianchi; Ho Sung Son; Changfu Wu; Christopher DeFilippi; Kai Xu; William J Lederer; Zhongjun J Wu; Bartley P Griffith
Journal:  JACC Cardiovasc Interv       Date:  2013-03-20       Impact factor: 11.195
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.